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study, a Rasch analysis will be performed and the validation
process will be completed with the remaining measurement prop-
erties (feasibility, validity, reliability and responsiveness to
change) and with a higher number of patients.
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OBJECTIVES: To reduce, score and assess the psychometric
properties of the Freedom from Glasses Value Scale (FGVS), a
new scale developed to measure beneﬁts of freedom from
glasses in cataract and presbyopic patients after multifocal
intraocular lens (IOL) surgery. METHODS: The FGVS, a
21-item Patient-Reported Outcomes instrument, was developed
simultaneously in French and Spanish. It was administered by
phone in a study conducted with 152 French and 152 Spanish
patients who underwent cataract or presbyopia surgery at least
1 year before the interview. Statistical methods (principal com-
ponent analysis, multi-trait analysis) and content analysis were
used to select the items and to score the FGVS. Psychometric
properties (validation of the structure, internal consistency reli-
ability, known-group validity) of the resulting version were
assessed in the pooled population and by country. RESULTS:
One item was removed from the FGVS, three motivation items
were kept but not aggregated in a dimension, and two main
dimensions were deﬁned (‘global evaluation’, 9 items; ‘advan-
tages’, 8 items). These two dimensions contain ﬁve subscores
(‘evaluation of the results’, 2 items; ‘feelings’, 4 items; ‘global
judgment’, 3 items; ‘psychological advantages’, 3 items; ‘prac-
tical advantages’, 5 items). A higher score indicates a higher
beneﬁt from surgery. The scores presented good psychometric
properties; all items met the convergent validity criterion and
only three did not meet the discriminant validity criterion.
Cronbach’s alpha was greater than 0.70 for all dimensions and
sub-dimensions (good internal consistency reliability), and the
FGVS was able to discriminate between patients wearing glasses
or not after surgery (higher scores for patients not wearing
glasses). FGVS scores were signiﬁcantly higher in Spain than in
France, however, they showed similar psychometric perfor-
mances in both countries. CONCLUSIONS: The FGVS is a
valid and reliable instrument measuring beneﬁts of freedom
from glasses perceived by cataract and presbyopic patients after
multifocal IOL surgery.
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OBJECTIVES: To ascertain the scoring and to assess the psycho-
metric properties of the Eye-Drop Satisfaction Questionnaire
(EDSQ). METHODS: The EDSQ was developed to assess the
satisfaction and compliance of patients with glaucoma treatment.
The hypothesised model content of the questionnaire resulting
from patient and clinician interviews organised 43 items into
six domains: Patients characteristics, Treatment characteristics,
Patient-clinician relationship, Patient experience, Patient-
treatment interaction, and Patient knowledge. The EDSQ was
included in a observational, multicenter study in France in
patients treated for glaucoma. The scoring of the EDSQ was
investigated by testing several possible structures, resulting from
the hypothesised model/Factor Analysis. Psychometric properties
of the retained structure were assessed: internal consistency reli-
ability (Cronbach’s alpha) and construct validity (multitrait
analysis). Distributional features (missing data, ceiling and ﬂoor
effects) of the EDSQ scores were scrutinised. RESULTS: Analyses
were performed with 169 patients who had completed more than
half of the EDSQ items. The retained structure, resulting from
Principal Component Analysis, included six domains: Concern
about treatment (5 items), Concern about disease (2 items),
Satisfaction with patient-clinician relationship (5 items), Positive
beliefs (3 items), Treatment convenience (3 items), and Declared
compliance (3 items). Items not included in the domains were
kept for separate analysis. Cronbach’s alpha of the domains was
greater than 0.7 for ﬁve domains and ranged from 0.65 to 0.90.
The structure offered good item convergent and item divergent
validity (range of item-scale correlation: 0.36–0.82). Moderate
ceiling effect was observed for the Satisfaction with patient-
clinician relationship score (20% at maximum score), reﬂecting
good relationships. An important ceiling effect was also observed
for the Declared compliance score, with patients declaring high
levels of compliance (49% at maximum score). CONCLU-
SIONS: The scoring of the EDSQ was developed and the ques-
tionnaire was shown to have satisfactory psychometric
properties.
PSS53
ATOPIC DERMATITIS IN PAEDIATRIC PATIENTS: COMMON
CAREGIVER BEHAVIOUR WHEN FACINGTHE DIFFERENT
DISEASE PRESENTATIONS OR LESION SEVERITY.
ELIBROT STUDY
Lahoz R1,Torrelo A2, Febrer I3, Lleonart M1
1Novartis Pharmaceuticals, Barcelona, Spain, 2Hospital Niño Jesús,
Madrid, Spain, 3Hospital General Universitario de Valencia,Valencia,
Spain
OBJECTIVES: To assess the parents’/caregivers’ behavior of the
pediatric patient with atopic dermatitis (AD) stratiﬁed by type,
severity and ﬂare-up area. METHODS: An epidemiological,
cross-sectional study in patients 2–12 years old with mild or
moderate AD and at least two ﬂares in the previous year, were
conducted in 451 paediatric sites. Patient characteristics and a
brief clinical history were asked to caregivers. Data about the
management and characteristics of ﬂares were requested to car-
egivers. The satisfaction with treatment use was also requested.
A logistic regression was performed to analyze the predictive
factors of worries to use corticosteroids. Moreover, the odds
ratio (OR) of them were calculated. RESULTS: A total of 1177
patients were included. A total of 52.3% boys with a mean
(SD) of 5.3(2.8) years old. A total of 66.4% of patients had
family history of AD, two third of them were parents. The
mean (SD) age at diagnosis was 1.6 (1.5). The lesions are
mainly presented in upper and lower extremities and face/neck
(>70%). The parents’/caregivers’ visits to the doctor was six
times greater for moderate episodes vs mild ones (OR = 6.15,
IC95%: 5.12–7.14; p < 0.0001). Regarding visits according to
age, there were an 8% visits decrease for each year of age
(OR = 0.92, IC95%: 0.89–0.96; p < 0.0001). A total of 19.3%
of caregivers never use corticosteroids in lesions on face/neck,
and 52.4% could use it only as an alternative option. However,
when lesions are presented in other parts of body, 48.9% of
caregivers use it as ﬁrst line option. The most commonly used
treatments are moisturizing products (31.0%), topical immuno-
modulators (30.3%) and strong corticosteroids (23.3%). There
are three predictive factors related to avoid use of corticoster-
oids: location in face/neck (OR = 4.47, IC95%: 3.50–5.72),
mild severity (OR = 1.98, IC95%: 1.48–2.66) and low age
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